Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30169296

NC(=O)CCCC(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.38
KMT2A Q03164 2/20 0.37
ALOX15 P16050 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
FAAH O00519 8/20 0.36
CES1 P23141 5/20 0.34
CES2 O00748 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HRH4 Q9H3N8 2/20 0.34
HRH3 Q9Y5N1 2/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC6 Q9UBN7 1/20 0.32
ODC1 P11926 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL30882498 1.00 SLC22A6 (0.38) SLC22A6KMT2AALOX15BLMPMP22
Succinamide SCHEMBL27483865 0.92 ALOX15 (0.39) KMT2AALOX15BLMPMP22FAAH
Trifluoroacetic Acid SCHEMBL6490884 0.87 LMNA (0.50) KMT2AALOX15BLMPMP22MEN1
Trifluoroacetic Acid SCHEMBL27386746 0.85 FAAH (0.50) KMT2AFAAHCES1CES2MEN1
Trifluoroacetic Acid SCHEMBL30164282 0.85 FAAH (0.50) KMT2AFAAHCES1CES2MEN1
Trifluoroacetic Acid SCHEMBL3149183 0.84 HRH4 (0.36) KMT2AALOX15BLMPMP22CYP1A2
Trifluoroacetic Acid SCHEMBL4701418 0.84 ALOX15 (0.34) KMT2AALOX15BLMPMP22NOS1
Trifluoroacetic Acid SCHEMBL30123527 0.84 LMNA (0.45) SLC22A6KMT2AALOX15BLMPMP22
Trifluoroacetic Acid SCHEMBL28761253 0.84 LMNA (0.54) KMT2AALOX15BLMMEN1CYP1A2
Trifluoroacetic Acid SCHEMBL7007737 0.84 FAAH (0.59) SLC22A6KMT2AALOX15FAAHCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059221-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2025-02-20 US disclosed
US-12077555-B2 STAT degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2024-09-03 US disclosed
WO-2024054919-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (CN) 2024-03-14 WO disclosed
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 US disclosed
US-20230120381-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-04-20 US disclosed
US-20230084113-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-03-16 US disclosed
CN-115776891-A STAT degradants and uses thereof 凯麦拉医疗公司 2023-03-10 CN disclosed
US-11485750-B1 STAT degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2022-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230084113-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 SLC22A6 4421/4885KMT2A 737/4885ALOX15 2745/4885
US-20230120381-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 SLC22A6 4421/4885KMT2A 737/4885ALOX15 2745/4885
US-12077555-B2 STAT degraders and uses thereof STAT4, STAT1, STAT3 SLC22A6 4421/4885KMT2A 737/4885ALOX15 2745/4885
US-20250059221-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 SLC22A6 4421/4885KMT2A 737/4885ALOX15 2745/4885
US-11746120-B2 Stat degraders and uses thereof STAT4, STAT1, STAT3 SLC22A6 4421/4885KMT2A 737/4885ALOX15 2745/4885
US-11485750-B1 STAT degraders and uses thereof STAT4, STAT1, STAT3 SLC22A6 4421/4885KMT2A 737/4885ALOX15 2745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.